Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Merck describes new selective alpha1a-adrenoceptor blockers and use in BPH

June 21, 1999

Dutasteride suppresses DHT levels more effectively, consistently than finasteride

June 21, 1999

Substantially pure (S)-(+)-enantiomer form of ETA antagonist prepared at Pfizer

June 15, 1999

Imidazotriazinones synthesized at Bayer inhibit cGMP-PDE isozymes

June 14, 1999

Tricyclic cGMP-PDE inhibitors for urinary incontinence and related disorders

June 8, 1999

New compounds from SS Pharm. with greater bladder selectivity than oxybutynin

June 7, 1999

Kissei presents binding profile and functional characterization of alpha1-adrenoceptor antagonist

June 3, 1999

Beta agonist KUL-1248, a novel agent for facilitating stone discharge and suppressing colic

June 3, 1999

Novel treatment for calcium oxalate stones presented at AUA

June 2, 1999

New treatment strategy for BPH: CRM197 inhibits bladder smooth muscle cell proliferation

June 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...